Christopher W. Cain - Mar 10, 2025 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role: Director
Signature: /s/ Jennifer Tousignant, Attorney-in-fact
Stock symbol: VRDN
Transactions as of: Mar 10, 2025
Transactions value $: $0
Form type: 3
Date filed: 3/12/2025, 04:17 PM
Previous filing: Jun 13, 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney